reference/9429609

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9429609

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1471-2407
issueIdentifier	1
pageRange	725-
publicationName	BMC Cancer
startingPage	725
bibliographicCitation	Melchardt T, Hufnagl C, Magnes T, Weiss L, Hutarew G, Neureiter D, Schlattau A, Moser G, Gaggl A, Tränkenschuh W, Greil R, Egle A. CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer. BMC Cancer. 2015 Oct 16;15():725. PMID: 26475344; PMCID: PMC4609094.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f730d1b4eda21b50d7c801b813293d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d8182367c359ae2ba2d9422d2e88dc5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34cb2170814410d41b2ccae85c6b80cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4916-5490 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4754ff71ce0ed674b35ce5eb82789661 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b6c9c4869e7ceba686882bb99767e08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b35bcb30f5c3694fb56437e5feba4a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31ab420c261c7be66e706927749bd766 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6dd99b4632b8394bced0a34d9327de3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_114e92606447e05660ec37a33ff8605c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02119971ec0c9c3d5dfac605b39d871b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54899819504d0bc10f5c7a72c6f80385 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0eb4148723e1b697d229916e4b87696f
date	2015-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/s12885-015-1776-x https://pubmed.ncbi.nlm.nih.gov/26475344 https://pubmed.ncbi.nlm.nih.gov/PMC4609094
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020 https://portal.issn.org/resource/ISSN/1471-2407
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
discusses	http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0457842 http://id.nlm.nih.gov/mesh/M0008631 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0020519
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_216b3f57d0f687434bc29fb5794589c0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e876a6499fb4e139e9f7d6960f968cb3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7905 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f28d9b6eeeb2b2619a0a1dd08a868432 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0b3d10eb956ff06dc6732f0ade26a205 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_12e4ad17b519957c896314136fc6daa3

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51302 http://rdf.ncbi.nlm.nih.gov/pubchem/conserveddomain/PSSMID410728

Total number of triples: 53.